Scleroderma Clinical Trials


Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma

Conditions:   Scleroderma;   Gastroparesis
Intervention:   Device: transcutaneous electroacupuncture
Sponsors:   Johns Hopkins University;   Transtimulation Research, Inc
Recruiting

Learn More

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Conditions:   Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions:   Drug: Oral Ifetroban;   Drug: Oral Placebo
Sponsor:   Cumberland Pharmaceuticals
Recruiting

Learn More

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Condition:   Scleroderma, Systemic
Interventions:   Drug: Nintedanib;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Recruiting

Learn More

Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis

Condition:   Scleroderma, Systemic
Interventions:   Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
Sponsor:   Bayer
Active, not recruiting

Learn More

Hormonal, Metabolic, and Signaling Interactions in PAH

Conditions:   Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:  
Sponsor:   Vanderbilt University
Recruiting

Learn More

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease

Conditions:   Scleroderma, Systemic;   Sclerosis, Systemic;   Systemic Scleroderma;   Systemic Sclerosis
Interventions:   Drug: Pomalidomide (CC-4047);   Drug: Placebo
Sponsor:   Celgene
Completed

Learn More

A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Conditions:   Scleroderma, Diffuse;   Scleroderma, Systemic
Interventions:   Drug: Abatacept;   Drug: Placebo
Sponsors:   Stanford University;   Bristol-Myers Squibb
Completed

Learn More

1-7 of 7
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.